Skip to content

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00687180
Enrollment
Unknown
Registered
2008-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2008-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Hepatitis

Keywords

Prednisolone dosage

Brief summary

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Interventions

DRUGTreatment with mycophenolat mofetil
DRUGTreatment with azathioprin

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* De novo autoimmune hepatitis * Consent

Exclusion criteria

* age below 18 * pregnancy

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026